Inhibitory effect of recombinant BCG containing the fusion gene BFNA on EB virus-positive tumors.

Appl Microbiol Biotechnol · 2025 · PMC12133901 · PMID 40459582

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantP ≤ 0.01actually significant

The titer of the antibody in the rBCG group was highly significant ( P ≤ 0.01), which delayed tumorigenesis, and the specific killing ability of rBCG targeting the recombinant target protein was increased.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.